Alpha Teknova, Inc. Common Stock TKNO
Analyst Ratings
- Consensus
- Buy — 3 Buy · 0 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $8.00 (+18.9% upside)
Key Stats
- Today's Range
- $6.67 – $7.07
- 50-Day Range
- $4.73 – $7.84
- 52-Week Range
- $1.91 – $7.84
- Volume
- 58K shs
- Average Volume
- 236K shs
- Market Cap
- $370.99 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.93
- Price / Sales
- 8.49
Short Interest
- Short Interest
- 0.07%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $43.70 million
- Net Income
- $-16,769,000
- Net Margin
- -38.37%
- Return on Equity
- -26.79%
- Debt-to-Equity
- 0.21
About Alpha Teknova, Inc. Common Stock
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
Related Stocks
Compare head-to-head: TKNO vs IDXX·TKNO vs LNTH·TKNO vs CLDX·TKNO vs NTLA
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.